Beacon

Designing an accessible website for ophthalmic gene therapy pioneer.

Challenge.

How do you design an accessible website from the ground up?

Beacon is a pioneer in ophthalmic gene therapy developing a cure for a rare condition that causes sight loss in primarily young men.

Following a recent rebrand, they needed a refreshed website that addressed diverse audience needs. From healthcare practitioners to investors, and, most importantly, patients considering participation in clinical trials, the website needed to be an inclusive platform.

The challenge laid in tailoring UX journeys to accommodate patients in early or late-stage sight loss. Balancing these functional needs with the visual identity of the new brand, our work extended beyond web design, into the realm of accessible web development.

/
/
/
/
/
/

Solution.

Delivering digital performance for Beacon

Understanding the diverse needs of Beacon’s audiences, we strategically developed a brand-new website that seamlessly merged functionality with accessibility.

Using a modern and flexible WordPress CMS, our solution involved a simplified approach to navigation to ensure a user-friendly experience, aligning with the inclusive platform Beacon aimed to establish. We implemented high-contrast colour schemes and customisable font sizes to cater to varying visual needs.

Additionally, interactive elements were designed with keyboard navigation in mind, guaranteeing an inclusive experience for users with different abilities. These features extended beyond conventional design considerations, striking a delicate balance with the visual identity of the brand.

/
/
/
/

Feedback.

"Beacon’s brand has proved hugely successful in defining our new identity and acting as an anchor point for the integration of legacy companies internally. The clarity of our brand has also been well received externally, with a simple message and clear lineage to our ophthalmology mission."

Ben Rigby – VP, Business Operations, Beacon

More.

Say hello or subscribe to get our latest news and insight.

Contact.